Maze Therapeutics, Inc. · NASDAQ:MAZE

Bernstein Harold sold 9,705 Maze Therapeutics, Inc. shares (Form 4)

Traded Sep 4, 2026 · Filed Sep 8, 2026

On Sep 4, 2026, Bernstein Harold (President, R&D & CMO) sold 9,705 Maze Therapeutics, Inc. shares at US$26.22 for US$254K under a trading plan, leaving 0 shares. Filed Sep 8, 2026 (Form 4).

Sold: 9,705 shares
Price: US$26.22
Value: US$254K
Holding after: 0 shares
Trading plan: Yes (Made under a plan set in advance)
Role: President, R&D & CMO

The filing in full

Date	Security	Transaction	Shares	Price	Holding after	Ownership
Sep 4, 2026	Common Stock	Sale	9,705	US$26.22	0	Direct

Source

View original at SEC

Related